The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Methylation profile of ER- and HER2-negative (ER-/HER2-) breast tumors.
M. T. Branham
No relevant relationships to disclose
D. M. Marzese
No relevant relationships to disclose
F. Gago
No relevant relationships to disclose
O. M. Tello
No relevant relationships to disclose
J. I. Orozco
No relevant relationships to disclose
L. M. Vargas-Roig
No relevant relationships to disclose
M. Roqué
No relevant relationships to disclose